MedTrace Logo

Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares

NCT00291031 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2013-10-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether Imagery Rehearsal Therapy(IRT) is effective in the reduction of the number of nightmares and the nightmare distress in a population of patients with psychiatric disorders.

Conditions

  • Nightmares
  • Anxiety Disorders
  • Mood Disorders
  • Personality Disorders

Interventions

BEHAVIORAL

Imagery Rehearsal Therapy (IRT)

Imagery Rehearsal Therapy is given by psychologists, psychotherapists or psychiatrists. The IRT therapists are all trained by Annette van Schagen, principal investigator. IRT consists of six 1-hour sessions. The six sessions are given in a period of three months. Each session is described in the IRT Manual. The IRT Manual is devised by the principal investigator Annette van Schagen in colaboration with Victor Spoormaker PhD. There is a patient version of the IRT manual available for the patients, which includes descriptions of the IRT sessions and homework assignments.

Sponsors & Collaborators

  • Utrecht University

    collaborator OTHER

  • GGZ Centraal

    lead OTHER

Principal Investigators

  • Annette M. van Schagen, MA · GGZ Centraal (previously Symfora groep)

  • Jan van den Bout, PhD · Utrecht University

  • Victor I. Spoormaker, PhD · Max-Planck-Institute of Psychiatry

  • Jaap Lancee, PhD · University of Amsterdam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2011-01-31
Completion
2011-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00291031 on ClinicalTrials.gov